Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI or "Marrone Bio"), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, has entered into a
Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.